Felocell FVR C (IN), Cat Vaccine, 25 x 1 ml tray

Description: Felocell FVR® C (IN) contains attenuated strains of feline rhinotracheitis virus and feline calicivirus propagated on an established feline cell line and freeze-dried to preserve stability. Contains gentamicin as preservative.
Indications: Felocell FVR® C (IN) is for intranasal vaccination of healthy cats as an aid in preventing feline rhinotracheitis (FVR) caused by feline herpesvirus-1 and feline respiratory disease caused by feline calicivirus (FCV).
Directions:
1. General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well. Using sterile dropper, inoculate nasal passages with entire volume of vaccine. Alternatively, 1 drop of vaccine may be placed in each eye and the remainder placed into nasal passages. Administer vaccine within 30 minutes after rehydration.
2. Primary Vaccination: Healthy cats 12 weeks of age or older should receive one 0.5-mL dose. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.
3. Revaccination: Annual revaccination with a single dose is recommended.
Precaution(s): Store at 2° - 7° C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Burn containers and all unused contents.
Caution(s): As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
Warning(s): Transient sneezing may be observed 4-7 days after vaccination. Oral lesions may be observed postvaccinally, but typically heal without incident. Vaccination of cats incubating or harboring latent infections may result in more pronounced upper respiratory signs, ocular irritation, or febrile response.
For intranasal use in cats only.
For veterinary use only.
Presentation: Cartons of 25 x 1 dose vials

Specifications

25x1 dose

call for pricing